ES2183944T3 - Proteina de 55 a 75 kda aislada que se une a proteinas prionicas. - Google Patents

Proteina de 55 a 75 kda aislada que se une a proteinas prionicas.

Info

Publication number
ES2183944T3
ES2183944T3 ES96912697T ES96912697T ES2183944T3 ES 2183944 T3 ES2183944 T3 ES 2183944T3 ES 96912697 T ES96912697 T ES 96912697T ES 96912697 T ES96912697 T ES 96912697T ES 2183944 T3 ES2183944 T3 ES 2183944T3
Authority
ES
Spain
Prior art keywords
isolated
joins
kda protein
prion proteins
prion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96912697T
Other languages
English (en)
Inventor
Ricardo R Brentani
Souza Sandro J De
Vilma R Martins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Application granted granted Critical
Publication of ES2183944T3 publication Critical patent/ES2183944T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION IMPLICA PROTEINAS DE UNION A PROTEINA ANTI PRION AISLADAS QUE POSEEN PESOS MOLECULARES DE APROXIMADAMENTE 55 KD A APROXIMADAMENTE 72 KD, DETERMINADOS POR SDS-PAGE. SE DESCRIBE ASIMISMO UN PEPTIDO DERIVADO DE UNA PROTEINA DE UNION A PROTEINA ANTI PRION AISLADA. SE DISCUTEN LOS USOS DIAGNOSTICOS DE CADA UNA DE DICHAS MOLECULAS.
ES96912697T 1995-04-12 1996-04-11 Proteina de 55 a 75 kda aislada que se une a proteinas prionicas. Expired - Lifetime ES2183944T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/421,059 US5679530A (en) 1995-04-12 1995-04-12 Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein

Publications (1)

Publication Number Publication Date
ES2183944T3 true ES2183944T3 (es) 2003-04-01

Family

ID=23669020

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96912697T Expired - Lifetime ES2183944T3 (es) 1995-04-12 1996-04-11 Proteina de 55 a 75 kda aislada que se une a proteinas prionicas.

Country Status (9)

Country Link
US (3) US5679530A (es)
EP (1) EP0822828B1 (es)
JP (1) JPH11504317A (es)
AT (1) ATE222767T1 (es)
AU (1) AU703571B2 (es)
CA (1) CA2217947A1 (es)
DE (1) DE69623272T2 (es)
ES (1) ES2183944T3 (es)
WO (1) WO1996032128A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679530A (en) * 1995-04-12 1997-10-21 Ludwig Institute For Cancer Research Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein
US6211149B1 (en) 1998-08-03 2001-04-03 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of formation of protease resistant prion protein
EP1187920A2 (en) * 1999-06-09 2002-03-20 Arch Development Corporation Recombinant prion-like genes and proteins and materials and methods comprising same
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
EP1210110A4 (en) * 1999-06-29 2003-03-19 Univ Mcgill PROTEINS BINDING TO PRION PROTEIN AND THEIR USE
AU2002258646A1 (en) * 2001-03-30 2002-10-15 Texas A And M University System Transgenic animals resistant to transmissible spongiform encephalopathies
US6613505B2 (en) 2001-04-12 2003-09-02 Bioresource International, Inc. Composition and method for destruction of infetious prion proteins
DE10155693A1 (de) * 2001-11-07 2003-05-15 Florian Schweigert Verfahren zum Nachweis von apathogenen Partikeln und deren pathogenen Varianten im Organismus
US20040072236A1 (en) 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
US7265248B1 (en) 2005-04-29 2007-09-04 Technology Innovations, Llc Compositions and methods for the treatment of malaria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679530A (en) * 1995-04-12 1997-10-21 Ludwig Institute For Cancer Research Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein

Also Published As

Publication number Publication date
DE69623272T2 (de) 2003-04-17
EP0822828A4 (en) 2000-10-25
EP0822828A1 (en) 1998-02-11
CA2217947A1 (en) 1996-10-17
US6350854B1 (en) 2002-02-26
AU5541896A (en) 1996-10-30
ATE222767T1 (de) 2002-09-15
EP0822828B1 (en) 2002-08-28
US5679530A (en) 1997-10-21
WO1996032128A1 (en) 1996-10-17
US6066320A (en) 2000-05-23
DE69623272D1 (de) 2002-10-02
AU703571B2 (en) 1999-03-25
JPH11504317A (ja) 1999-04-20

Similar Documents

Publication Publication Date Title
DE69533748D1 (de) Immunsuppressive proteinziele
CO5050400A1 (es) Proteina de chlamydia, secuencia de genes y anticuerpos para ello
ES2149206T3 (es) Purificacion de proteinas.
BR9507100A (pt) Purificação de anticorpos
ES2183944T3 (es) Proteina de 55 a 75 kda aislada que se une a proteinas prionicas.
DE69330643D1 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon
DE69702911T2 (de) Oxydierte oligosaccharide
ATE229542T1 (de) Fusionspolypeptid zur beeinflussung von wechselwirkungen zwischen proteinen
ES2076999T3 (es) Peptidos anticoagulantes radiomarcados.
NO904292D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
SE9003374D0 (sv) A collagen binding protein as well as its preparation
DK0540574T3 (da) Antikoagulationspeptider
NO894880L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.